Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Results of the LEVEL Study

  Channels: Retina | Posted 5/19/2010

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.


Related Videos